What is methylene blue FDA approved for?
•
5 min read
Acquired methemoglobinemia is an uncommon but potentially fatal condition, with an overall prevalence as low as 0.035% in some procedural settings [1.13.3]. The primary question for clinicians is, **what is methylene blue FDA approved for** in treating this and other conditions? The answer is specific and critical for patient safety.
